Heart age report: a simple tool to spark better blood pressure Self-Care?

NCT ID NCT07045363

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial tests whether giving older adults with hypertension a personalized 'Heart Age' report during a routine doctor's visit can boost their awareness of cardiovascular risk and encourage healthier habits. Participants receive a one-page report based on their annual health check data, explained by a trained physician. The study compares their progress against a control group receiving usual care, focusing on changes in risk knowledge and physical activity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A personalized one-page Heart Age report delivered by trained physicians during routine follow-up visits
What this could lead to
If effective, this simple educational tool could be integrated into routine primary care to help older adults with hypertension better understand and manage their cardiovascular risk.
What could go wrong
The trial is relatively small and the outcome relies on self-reported behavior changes, which may not translate to long-term health improvements. The intervention's success depends on physician delivery and patient engagement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

358 people

The number who actually took part.

Started

Aug 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥60 years * Diagnosed with hypertension * Completed their government-funded annual health check within the past 3 months * Scheduled for a routine follow-up consultation within the enrollment window -Able to provide informed consent- Exclusion Criteria: * Diagnosed dementia or severe cognitive impairment * Terminal illness * Participation in another clinical intervention trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Education hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tinglin Community Health Center

    Suzhou, Jiangsu, 215316, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.